initial public issue of 21,50,000 equity shares of face value of Rs. 10/- each of Curis Lifesciences Limited ("Curis" or the "company" or the "Issuer") for cash at a price of Rs. [*]/- per equity share including a share premium of Rs. [*]/- per equity share (the "Issue Price") aggregating to Rs. [*] crores ("the Issue"), of which 1,08,000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. [*]/- per equity share including a share premium of Rs. [*]/- per equity share aggregating to Rs. [*] crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of 20,42,000 equity shares of face value of Rs. 10/- each at a price of Rs. [*]/- per equity share including a share premium of Rs.[*]/- per equity share aggregating to Rs. [*] crores is herein after referred to as the "Net Issue". The issue and the net issue will constitute 26.59% and 25.26%, respectively, of the post issue paid up equity share capital of the company.
The face value of the equity shares is Rs. 10/- each.
Price band: Rs 120/- to Rs 128/- per equity share of face value Rs. 10/- each.
The floor price is 12 times of the face value and the cap price is 12.80 times of the face value of the equity shares.
Bid can be made for a minimum of 2000 equity shares and in multiple of 1000 equity shares thereafter.
Issue
Money Payable On
Opens On
Closes On
Application
Allotment
07-Nov-2025
11-Nov-2025
₹ 120.00
₹ 0.00
Minimum Application for shares in Nos : 2000.0
Further Multiples of : 1000.0
(₹)Cr.
Lead Managers to the Issue
Project Cost
0.00
Finaax Capital Advisors Private Limited
Project Financed through Current Offer
25.80
Post Issue Equity Share Capital
8.08
Issue Price
₹120.00
Projects
Funding capital expenditure towards improvement of its existing mfg facility at
Repayment of secured loans outstanding in the name of company